Begin typing your search...
Lupin incorporates unit in US to focus on oncology products
Drug maker Lupin on Tuesday said it has incorporated a wholly-owned subsidiary in the US.
By
migrator
migrator
New Delhi
The new unit, Lupin Oncology Inc (LOI), will be engaged in development/co-development and commercialisation of multiple oncology products globally, the Mumbai-based company said in a regulatory filing.
Lupin has a sizable presence in the US market, the world's biggest market for pharma products.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android
Next Story
